• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session

    7/8/24 8:22:50 AM ET
    $ADCT
    $ARQT
    $AS
    $INTA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADCT alert in real time by email

    U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Monday.

    Shares of Intapp, Inc.  (NASDAQ:INTA) fell sharply in today's pre-market trading after Oppenheimer downgraded the stock from Outperform to Perform.

    Intapp shares tumbled 4.5% to $ 34.67 in the pre-market trading session.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shares dipped 16.2% to $8.79 in pre-market trading. Arcutis Biotherapeutics, last week, reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) shares declined 6.4% to $20.70 in pre-market trading.
    • ADC Therapeutics SA (NASDAQ:ADCT) shares fell 5.5% to $3.08 in pre-market trading. Myricx Bio announced the closing of its series A financing raising £90 million ($114 million).
    • Stitch Fix, Inc. (NASDAQ:SFIX) declined 5.3% to $3.95 in pre-market trading after gaining over 7% on Friday.
    • Amer Sports, Inc. (NYSE:AS) shares fell 4.1% to $11.50 in pre-market trading after declining over 4% on Friday.
    • XPeng Inc. (NYSE:XPEV) shares slipped 3.9% to $7.61 in pre-market trading after falling around 5% on Friday.
    • Lufax Holding Ltd (NYSE:LU) shares fell 3.4% to $2.85 in pre-market trading.
    • ServiceNow, Inc. (NYSE:NOW) shares fell 3.2% to $781.00 in pre-market trading. ServiceNow is expected to release financial results for the second quarter, after the closing bell on Wednesday, July 24.

    Now Read This: Fear & Greed Index Moves To ‘Neutral’ Zone As S&P 500 Hits Record High After Friday Jobs Data

    Don't forget to check out our premarket coverage here

    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ARQT
    $AS
    $INTA

    CompanyDatePrice TargetRatingAnalyst
    Amer Sports Inc.
    $AS
    2/25/2026$50.00 → $51.00Outperform
    Evercore ISI
    ServiceNow Inc.
    $NOW
    1/29/2026$175.00 → $170.00Outperform
    BMO Capital Markets
    ServiceNow Inc.
    $NOW
    1/21/2026$230.00 → $175.00Outperform
    BMO Capital Markets
    ServiceNow Inc.
    $NOW
    1/12/2026$205.00Buy
    Goldman
    Amer Sports Inc.
    $AS
    1/8/2026Buy
    Deutsche Bank
    ServiceNow Inc.
    $NOW
    1/6/2026$200.00Neutral → Buy
    Arete
    ServiceNow Inc.
    $NOW
    12/17/2025$1000.00Buy
    BTIG Research
    ServiceNow Inc.
    $NOW
    12/16/2025Sell → Neutral
    Guggenheim
    More analyst ratings

    $ADCT
    $ARQT
    $AS
    $INTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Global Customer Ops Fipps Paul sold $376,142 worth of shares (3,696 units at $101.77), decreasing direct ownership by 31% to 8,061 units (SEC Form 4)

    4 - ServiceNow, Inc. (0001373715) (Issuer)

    2/25/26 4:32:25 PM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    Chief Marketing Officer Sedgwick Dustin De Forest converted options into 4,863 shares and covered exercise/tax liability with 1,482 shares, increasing direct ownership by 190% to 5,156 units (SEC Form 4)

    4 - Intapp, Inc. (0001565687) (Issuer)

    2/20/26 4:22:36 PM ET
    $INTA
    Computer Software: Prepackaged Software
    Technology

    Chief People & Places Officer Murgel Michele was granted 19,002 shares, converted options into 4,439 shares and covered exercise/tax liability with 8,850 shares, increasing direct ownership by 7% to 233,810 units (SEC Form 4)

    4 - Intapp, Inc. (0001565687) (Issuer)

    2/20/26 4:20:28 PM ET
    $INTA
    Computer Software: Prepackaged Software
    Technology

    $ADCT
    $ARQT
    $AS
    $INTA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    12/15/23 5:01:31 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ARQT
    $AS
    $INTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intapp announces Partner Forum 2026 Award winners

    Awards celebrate our partners' dedication to innovation, collaboration, and client success Intapp (NASDAQ:INTA), the leading governed AI platform for professional firms in highly regulated industries, today announced the winners of its Partner Forum 2026 Awards. The awards recognize demonstrable client success in five categories: Data Intelligence, Integration Excellence, Client Impact, Deal Catalyst, and Industry Showcase. The 2026 winners are: Moody's: Intapp Data Intelligence Award — Moody's was chosen for its excellence in integrating its data to deliver deeper insights, enhanced decision-making, and measurable value to clients. FINTRX: Intapp Integration Excellence Award — F

    2/26/26 5:30:00 PM ET
    $INTA
    Computer Software: Prepackaged Software
    Technology

    ServiceNow launches Autonomous Workforce that thinks and acts; adds Moveworks to the ServiceNow AI Platform

    AI specialists execute work with the scope, authority, and governance required for business New ServiceNow EmployeeWorks solution connects conversational AI chat and enterprise search from Moveworks with autonomous workflows for nearly 200 million employees ServiceNow (NYSE:NOW), the AI control tower for business reinvention, today launched Autonomous Workforce, AI specialists that can execute jobs with the scope, authority, and governance required for enterprise work – freeing people to focus on strategic problem solving and personalized service. Just two months after the Moveworks acquisition close, the company also introduced ServiceNow EmployeeWorks, which combines Moveworks' conver

    2/26/26 9:00:00 AM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    Intapp announces Celeste: Agentic AI for professional firms

    New platform provides industry expert agents and governed AI for professional compliance Intapp (NASDAQ:INTA), the leading governed AI platform for professional firms in highly regulated industries, announced the launch of Intapp Celeste — a purpose-built agentic AI platform. The new solution was announced today at Intapp's annual product event in New York City. Today's leading firms are ready for AI that sits at the heart of their organization — automating and orchestrating the core value chains that define success: fundraising and origination, business development and cross-selling, client intake and conflicts clearance, and profitable work delivery. These complex, deeply interconnect

    2/25/26 5:00:00 PM ET
    $INTA
    Computer Software: Prepackaged Software
    Technology

    $ADCT
    $ARQT
    $AS
    $INTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI reiterated coverage on Amer Sports with a new price target

    Evercore ISI reiterated coverage of Amer Sports with a rating of Outperform and set a new price target of $51.00 from $50.00 previously

    2/25/26 8:16:54 AM ET
    $AS
    Apparel
    Consumer Discretionary

    BMO Capital Markets reiterated coverage on ServiceNow with a new price target

    BMO Capital Markets reiterated coverage of ServiceNow with a rating of Outperform and set a new price target of $170.00 from $175.00 previously

    1/29/26 6:55:07 AM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on ServiceNow with a new price target

    BMO Capital Markets reiterated coverage of ServiceNow with a rating of Outperform and set a new price target of $175.00 from $230.00 previously

    1/21/26 8:06:01 AM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    $ADCT
    $ARQT
    $AS
    $INTA
    SEC Filings

    View All

    SEC Form 20-F filed by Amer Sports Inc.

    20-F - Amer Sports, Inc. (0001988894) (Filer)

    2/25/26 9:51:36 PM ET
    $AS
    Apparel
    Consumer Discretionary

    SEC Form S-8 filed by Arcutis Biotherapeutics Inc.

    S-8 - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)

    2/25/26 4:19:27 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3ASR filed by Arcutis Biotherapeutics Inc.

    S-3ASR - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)

    2/25/26 4:16:34 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ARQT
    $AS
    $INTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Heron Patrick J bought $34,610 worth of shares (2,646 units at $13.08) (SEC Form 4)

    4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)

    6/17/25 5:45:01 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Heron Patrick J bought $30,247 worth of shares (2,268 units at $13.34) (SEC Form 4)

    4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)

    6/6/25 8:44:37 AM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Heron Patrick J bought $68,821 worth of shares (5,040 units at $13.65) (SEC Form 4)

    4 - Arcutis Biotherapeutics, Inc. (0001787306) (Issuer)

    5/23/25 4:04:50 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ARQT
    $AS
    $INTA
    Leadership Updates

    Live Leadership Updates

    View All

    ServiceNow appoints Hossein Nowbar as President and CLO

    ServiceNow (NYSE NOW), the AI control tower for business reinvention, today announced that Hossein Nowbar has joined the company as President and Chief Legal Officer (CLO). Russ Elmer, who has served as Chief Legal Officer since 2018, will transition to the role of Special Counsel, where he will continue to provide strategic guidance and ensure continuity on key legal and corporate matters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105439880/en/ Most recently serving as Chief Legal Officer and Corporate Vice President at Microsoft Corporation, Nowbar brings extensive experience shaping policy priorities, fostering public

    1/5/26 1:00:00 PM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri

    WESTLAKE VILLAGE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Amit Munshi has been appointed to the Arcutis Board of Directors effective December 4, 2025, and announced the retirement of founder and long-serving Board member Bhaskar Chaudhuri, PhD. Dr. Chaudhuri will continue as a consultant for the Company. "As Arcutis looks to continue to grow in this next chapter, we are delighted to welcome Amit, an exceptional and visionary biopharmaceutical leader, to the Arcutis Board," said Frank Watanabe, president and chi

    12/8/25 4:00:00 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZIM Updates on Withholding Tax Procedures on December 2025 Cash Dividend

    HAIFA, Israel, Dec. 1, 2025 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company"), a global container liner shipping company, hereby updates that in connection with the dividend distribution expected to take place on December 8, 2025, as previously announced by the Company on November 20, 2025 (the "Dividend"), the previously obtained tax ruling from the Israeli Tax Authority ("ITA") on tax withholding procedures relating to the payment of the Dividend to the Company's shareholders (the "Ruling") shall apply. As a result of the Ruling, certain shareholders of the Company ("Shareholders") may be eligible to a reduced Israeli withholding tax rate with respe

    12/1/25 7:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $ADCT
    $ARQT
    $AS
    $INTA
    Financials

    Live finance-specific insights

    View All

    Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    Q4 2025 net product revenue for ZORYVE® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product revenue for ZORYVE was $372.1 million, an increase of 123% over the prior yearReported positive topline data for the INTEGUMENT-INFANT Phase 2 trial of ZORYVE cream 0.05% in children ages 3 to 24 months with mild to moderate atopic dermatitis, with a Supplemental New Drug Application (sNDA) submission expected in Q2 2026Announced expansion of its dermatology sales force and, separately, the initiation of a targeted Arcutis commercialization effort for primary care and pediatric health care providersProduced positive op

    2/25/26 4:00:00 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amer Sports Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides 2026 Outlook

    Strong full year 2025 performance with 27% revenue growth and more than 150 bps of operating margin expansion Strong Q4 results with Group revenues, adjusted margins and EPS above guidance Revenue grew 28% to $2,101 million, and strong momentum continues into 1Q26 Operating margin declined approximately 100 bps due to accelerated SG&A investment supporting key growth opportunities, particularly Salomon Softgoods All four regions achieved solid double-digit revenue growth Technical Apparel grew 34%, with broad-based strength across regions, categories and channels Outdoor Performance grew 29% driven by continued excellent momentum in Salomon footwear and a strong performa

    2/24/26 6:00:00 AM ET
    $AS
    Apparel
    Consumer Discretionary

    Stitch Fix Announces Date for Second Quarter 2026 Financial Results and Conference Call

    Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release financial results for its second quarter fiscal year 2026 ended January 31, 2026 after market close on Wednesday, March 11, 2026. Following this, Stitch Fix will hold a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results and outlook. The call will be hosted by Matt Baer, CEO, and David Aufderhaar, CFO. A live webcast of the call will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. To access the call by phone, please register at this registration link. Upon registration, telephone particip

    2/18/26 4:05:00 PM ET
    $SFIX
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADCT
    $ARQT
    $AS
    $INTA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Amer Sports Inc.

    SC 13D/A - Amer Sports, Inc. (0001988894) (Subject)

    12/12/24 7:02:15 PM ET
    $AS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Amer Sports Inc.

    SC 13D/A - Amer Sports, Inc. (0001988894) (Subject)

    12/10/24 4:00:24 PM ET
    $AS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Lufax Holding Ltd

    SC 13D/A - Lufax Holding Ltd (0001816007) (Subject)

    12/9/24 6:12:27 AM ET
    $LU
    Finance: Consumer Services
    Finance